Peter Chang1 | Vidya Perera 2,* | David H. Salinger1 | Samira Merali2 | Neelima Thanneer2 | Hyunmoon Back2 | Julie D. Seroogy et...al.2024-09-032024-09-032024-09-03http://98.70.32.231:4000/handle/123456789/1346Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration : CPT: Pharmacometrics & Systems PharmacologyArticle